Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS considers adverse events disclosures

This article was originally published in The Gray Sheet

Executive Summary

Medicare agency is evaluating whether it should post the incidences of hospital-acquired conditions on its Hospital Compare Web site, according to Jan. 5 memo from the HHS Office of Inspector General. "CMS contracted for the evaluation in September 2009, and will determine the extent of disclosure after findings are known," OIG said. CMS may release results from the evaluation focused on the Medicare agency's hospital-acquired conditions policy, its effects on Medicare reimbursement, utilization, quality, patient safety and unintended consequences. Because Medicare claims data lack information on causes of adverse events or prevention strategies, the agency may seek to combine it with data from other systems. The OIG memo cautions that some stakeholders are worried that public disclosure of adverse events can undermine patient privacy

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel